KALA BIO
KALA
61 hedge funds and large institutions have $452M invested in KALA BIO in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 9 closing their positions.
189% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 9
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
51% more capital inflows, than outflows
Capital inflows: $97.7M | Capital outflows: $64.5M
40% more call options, than puts
Call options by funds: $3.7M | Put options by funds: $2.64M
39% more funds holding
Funds holding: 44 → 61 (+17)
3.54% more ownership
Funds ownership: 73.57% → 77.11% (+3.5%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.4M |
| 2 |
BlackRock
New York
|
+$14.4M |
| 3 |
Eventide Asset Management
Boston,
Massachusetts
|
+$5.95M |
| 4 |
Citigroup
New York
|
+$5.1M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Caxton Corporation
Princeton,
New Jersey
|
-$14.4M |
| 2 |
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$6.8M |
| 3 |
Sofinnova Investments
Menlo Park,
California
|
-$6.8M |
| 4 |
Millennium Management
New York
|
-$5.1M |
| 5 |
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$4.97M |
KALA Hedge Fund Activity: Q2 2020 in Review
61 of the 4,891 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q2 2020, worth a combined $452M — up 28% from $353M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new KALA positions and 9 closed out — a net gain of 17 holders — while 14 added to existing stakes and 9 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $20.4M. The largest seller was Caxton Corporation, cutting an estimated $14.4M.
- 61 institutional investors held KALA BIO (KALA) as of Q2 2020, up from 44 in Q1 2020.
- Funds reported $452M of KALA BIO stock for Q2 2020, up 28% quarter-over-quarter.
- 26 funds opened new KALA BIO positions in Q2 2020 and 9 closed out, a net change of +17 holders.
- The largest KALA BIO buyer in Q2 2020 was Fidelity Investments, an estimated $20.4M added.
- The largest KALA BIO seller in Q2 2020 was Caxton Corporation, an estimated $14.4M sold.
Based on aggregated 13F filings for Q2 2020.